BMC Medical Genomics

Scope & Guideline

Connecting Researchers to Shape the Future of Medical Genomics

Introduction

Explore the comprehensive scope of BMC Medical Genomics through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore BMC Medical Genomics in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN-
PublisherBMC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationBMC MED GENOMICS / BMC Med. Genomics
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

BMC Medical Genomics focuses on advancing the understanding of genomic medicine through comprehensive analyses of genetic and genomic data across various medical conditions. The journal aims to publish high-quality research that employs cutting-edge methodologies to explore the genetic underpinnings of diseases, with a strong emphasis on translational applications in clinical settings.
  1. Genetic and Genomic Analysis:
    The journal emphasizes studies that utilize genetic and genomic analysis, including whole-exome sequencing and genome-wide association studies (GWAS), to identify variants associated with diseases.
  2. Bioinformatics and Computational Biology:
    BMC Medical Genomics publishes papers that apply bioinformatics and computational biology methods for analyzing large genomic datasets, facilitating the identification of key biomarkers and therapeutic targets.
  3. Translational Research:
    Research that bridges the gap between laboratory findings and clinical applications is a core focus, aiming at improving diagnostics, prognostics, and treatment strategies based on genomic insights.
  4. Molecular Mechanisms of Disease:
    The journal covers studies investigating the molecular mechanisms underlying various diseases, including cancer, genetic disorders, and metabolic diseases, highlighting how genetic variations impact disease pathology.
  5. Personalized Medicine:
    A strong emphasis is placed on research that contributes to the field of personalized medicine, utilizing genomic data to tailor medical treatment to individual patients.
BMC Medical Genomics has witnessed a surge in interest in several emerging themes that reflect the evolving landscape of genomic research. These trends highlight the journal's commitment to addressing contemporary challenges in genomics and medicine.
  1. Machine Learning Applications in Genomics:
    There is an increasing trend in the application of machine learning techniques to analyze genomic data, aiming to enhance predictive modeling and improve understanding of complex diseases.
  2. Long Non-Coding RNAs (lncRNAs):
    Research focusing on lncRNAs and their roles in gene regulation and disease mechanisms is gaining traction, reflecting a broader recognition of their importance in genomics.
  3. Integration of Multi-Omics Data:
    Studies that integrate genomic, transcriptomic, proteomic, and metabolomic data are on the rise, enabling a more comprehensive understanding of biological processes and disease pathways.
  4. Genomic Medicine and Personalized Healthcare:
    There is a growing emphasis on research that directly contributes to genomic medicine and personalized healthcare, focusing on how genomic insights can guide treatment decisions and patient management.
  5. Immunogenomics:
    Research exploring the interactions between the immune system and genetic factors, particularly in the context of cancer immunotherapy and autoimmune diseases, is increasingly prominent.

Declining or Waning

While BMC Medical Genomics continues to thrive in various research areas, certain themes have shown signs of declining prominence in recent years. This may reflect shifts in research focus or advancements in methodologies that render previous approaches less relevant.
  1. Traditional Genetic Mapping:
    Research focused solely on traditional genetic mapping techniques has decreased as more advanced methodologies, such as next-generation sequencing and whole-genome sequencing, become prevalent.
  2. Cohort Studies with Limited Genomic Insight:
    Papers that present cohort studies without substantial genomic analysis or insights into genetic variants are less frequently published, as the field moves towards more integrative approaches.
  3. Single-Locus Studies:
    There is a waning interest in studies that focus on single-locus associations, as multi-locus and polygenic approaches are increasingly favored for their ability to capture complex genetic interactions.
  4. General Population Studies:
    Research that addresses genetic factors in general populations without a specific focus on clinical applications or translational impact has seen a decline, reflecting a shift towards more targeted and clinically relevant investigations.

Similar Journals

npj Genomic Medicine

Bridging Science and Healthcare through Genomics
Publisher: NATURE PORTFOLIOISSN: Frequency: 1 issue/year

npj Genomic Medicine is a leading open-access journal published by NATURE PORTFOLIO, specializing in the rapidly evolving areas of genomic medicine, including genetics, molecular biology, and clinical applications. Launched in 2016, the journal has quickly established itself within the academic community, boasting a prestigious Q1 ranking in multiple categories, including Genetics and Molecular Biology, with remarkable positions in both Scopus ranks and percentiles. With an emphasis on innovative genomic research that bridges the gap between laboratory findings and clinical implementation, npj Genomic Medicine aims to provide a platform for researchers, professionals, and students to share significant advancements and insights. Being an open-access journal enhances accessibility to cutting-edge research, ensuring that vital discoveries in genomics can benefit a global audience and facilitate interdisciplinary collaboration. The journal continues to contribute to the forefront of genomic research, impacting both academic scholarship and practical healthcare solutions.

ANIMAL GENETICS

Connecting Research and Practice in Animal Genetics
Publisher: WILEYISSN: 0268-9146Frequency: 6 issues/year

ANIMAL GENETICS, published by WILEY, is a leading journal in the fields of Animal Science and Zoology, with a commendable Q1 classification for 2023, reflecting its critical role in advancing research and knowledge in animal genetics. Established in 1986, this journal has become a cornerstone for professionals, researchers, and students alike, providing a platform for innovative research that explores the genetic underpinnings of animal biology. With an ISSN of 0268-9146 and an E-ISSN of 1365-2052, it boasts a significant impact in both agricultural and biological sciences, as indicated by its ranking of #74 out of 490 in its category on Scopus, positioning it in the 85th percentile for Animal Science and Zoology. Readers can access high-quality, peer-reviewed articles that not only illuminate current advancements but also foster future research directions. While currently not an open access journal, ANIMAL GENETICS remains vital for anyone engaged in the exploration of genetics and its applications in medicine and beyond, with a continual commitment to publishing findings that shape the future of animal breeding, conservation, and genetics research.

Microbial Genomics

Empowering Research with Transparent Science
Publisher: MICROBIOLOGY SOCISSN: 2057-5858Frequency: 12 issues/year

Microbial Genomics, an esteemed journal published by the Microbiology Society, is a leading platform dedicated to the rapidly evolving field of microbial genomics. Since its transition to Open Access in 2016, this journal has consistently aimed to promote unprecedented transparency and accessibility in scientific research. Based in the United Kingdom, Microbial Genomics serves a diverse international audience, providing an invaluable resource for researchers, professionals, and students interested in genomics, microbiology, and related fields. With impressive quartile rankings in 2023, including Q1 status in Epidemiology, Genetics, and Microbiology, alongside strong performance in other categories, the journal is positioned at the forefront of academic discourse and innovation. This journal's commitment to excellence is not only reflected in its rigorous peer-review process but also in its dedication to showcasing groundbreaking research that informs current practices and shapes future trends in microbial science. As researchers explore the intricacies of microbial genomes, Microbial Genomics remains an essential resource fostering knowledge and collaboration in the scientific community.

G3-Genes Genomes Genetics

Championing High-Quality Research in Genomics
Publisher: OXFORD UNIV PRESS INCISSN: 2160-1836Frequency: 12 issues/year

G3-Genes Genomes Genetics is a prominent open access journal published by Oxford University Press, Inc., dedicated to advancing the field of genetics and genomics. Since its inception in 2011, the journal has become a vital resource for researchers, professionals, and students, featuring high-quality, peer-reviewed articles that cover a broad spectrum of topics within genetics, including clinical genetics and molecular biology. With an impressive standing reflected in its 2023 Scopus rankings, which positions it in the Q2 category for Genetics (Clinical) and Q1 for Medicine (Miscellaneous), G3 remains at the forefront of scholarly communication in these disciplines. The journal's commitment to open access ensures that cutting-edge research is accessible to a global audience, stimulating collaboration and innovation in the field. For those eager to explore the latest in genetic research, G3 serves as an indispensable platform, inviting contributions that push the boundaries of scientific understanding.

BMC GENOMICS

Catalyzing scientific discovery in the world of genomics.
Publisher: BMCISSN: 1471-2164Frequency: 1 issue/year

BMC Genomics is a premier open-access journal dedicated to advancing the field of genomics through the dissemination of high-quality research articles. Published by BMC, a renowned leader in open-access publishing, this journal has built a solid reputation since its inception in 2000, making significant contributions to the areas of biotechnology and genetics. Holding a prestigious Q1 ranking in Biotechnology and Q2 in Genetics as of 2023, it serves as an essential platform for researchers, professionals, and students alike, facilitating the exchange of innovative ideas and data. With an impactful presence in the Scopus rankings, BMC Genomics currently stands at Rank #90/347 in Genetics, reflecting its influence in the scientific community. Researchers are encouraged to explore the vast array of scholarly articles and engage with cutting-edge genomics research that is crucial for the evolution of various applications in medicine, agriculture, and environmental science. With its open access model, BMC Genomics ensures that groundbreaking research is freely available, fostering collaboration and accelerating scientific discovery on a global scale.

NAR Genomics and Bioinformatics

Bridging Theory and Application in Genomics and Bioinformatics
Publisher: OXFORD UNIV PRESSISSN: Frequency: 4 issues/year

NAR Genomics and Bioinformatics, published by Oxford University Press, is a leading open-access journal that has been at the forefront of research in genomics and computational biology since its inception in 2019. With an impressive impact factor and a consistent ranking in the Q1 category across multiple fields—namely Applied Mathematics, Computer Science Applications, Genetics, Molecular Biology, and Structural Biology—this journal stands as an influential platform for disseminating innovative findings and methodologies. Researchers and professionals have the opportunity to engage with high-quality, peer-reviewed articles that reflect the latest advancements in both theoretical and applied aspects of bioinformatics. The journal's commitment to open access ensures that groundbreaking research is accessible to a global audience, fostering collaboration and knowledge sharing within the scientific community. The country of publication is the United Kingdom, with a dedicated editorial team striving to maintain the highest standards of academic excellence.

Global Medical Genetics

Transforming Healthcare Through Genetic Insights
Publisher: GEORG THIEME VERLAG KGISSN: 2699-9404Frequency: 4 issues/year

Global Medical Genetics is a premier open-access journal dedicated to advancing the field of medical genetics. Published by GEORG THIEME VERLAG KG, this journal has been providing a dynamic platform for disseminating cutting-edge research and clinical findings since its inception in 2020. With the ISSN 2699-9404, it serves as an essential resource for researchers, healthcare professionals, and students who seek to explore the complex interplay between genetics and medicine. The journal aims to foster collaboration and innovation in the genetics community, addressing a diverse range of topics from genetic disorders to the application of genomics in personalized medicine. By providing open access to its content, Global Medical Genetics enhances knowledge sharing and accelerates advancements in healthcare, making it a vital asset for anyone invested in the future of genetics.

CURRENT GENOMICS

Illuminating the path of genetic discovery.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1389-2029Frequency: 8 issues/year

CURRENT GENOMICS is a premier journal published by Bentham Science Publishers that focuses on the expansive field of genomics, including both clinical and molecular genetics. With the ISSN 1389-2029 and E-ISSN 1875-5488, this esteemed journal has been disseminating significant scientific insights since its inception in 2000 and continues to contribute to the field through 2024. Based in the United Arab Emirates, CURRENT GENOMICS boasts a Q3 ranking in both the genetics and clinical genetics categories for 2023, reflecting its growing impact in the scientific community. Although not an open-access journal, it provides valuable content that supports researchers and professionals in navigating the complexities of genetic research and its applications. By publishing original research articles, reviews, and case studies, CURRENT GENOMICS aims to foster a deeper understanding of genomic science and its implications for medicine, thus playing a critical role in the advancement of genetics and biomedical research.

GENOME RESEARCH

Transforming Genetic Research into Clinical Impact
Publisher: COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPTISSN: 1088-9051Frequency: 12 issues/year

Genome Research, published by Cold Spring Harbor Laboratory Press, stands as a premier journal in the field of genetics, featuring rigorous peer-reviewed research that explores the complexities of genome organization and function. With an impressive Q1 ranking in both Genetics and Clinical Genetics according to the 2023 category quartiles, this journal effectively bridges the gap between fundamental genetic science and its clinical applications. Its significance is further highlighted by its Scopus rankings, where it ranks #6 out of 99 in Clinical Genetics and #27 out of 347 in Biochemistry, Genetics, and Molecular Biology, showcasing its broad influence and access to cutting-edge discoveries. Researchers and professionals can look forward to a diverse array of articles that cover genomic technologies, bioinformatics, and translational genomics. Although not currently open access, the wealth of information available in each issue makes it an invaluable resource for anyone engaged in genetic research and applications.

Genes

Empowering discoveries that transform genetic research.
Publisher: MDPIISSN: Frequency: 12 issues/year

Genes is a leading open-access journal published by MDPI that focuses on advancing the field of genetics and genomics. Established in 2010 and based in Basel, Switzerland, this journal has made significant strides in promoting innovative research in both clinical genetics and molecular biology. With an impact factor reflecting its relevance and quality, Genes has been classified in the Q2 quartile for Genetics and the Q3 quartile for clinical Genetics as of 2023. The journal provides an accessible platform for researchers, professionals, and students to disseminate their findings and explore emerging trends across the genetics landscape. Accessible online since its inception, Genes allows for continuous engagement and collaboration within the scientific community, fostering a deeper understanding of genetic mechanisms and their implications in health and disease.